//fpnotebook.com/
Triphasil
Aka: Triphasil, Trinordiol, Logynon, Trivora, Enpresse
- See Also
- Oral Contraceptive
- Oral Contraceptive Drug Interaction
- Oral Contraceptive Selection
- Oral Contraceptive Side Effect Management
- Oral Contraceptive-Related Uterine Bleeding Management
- Preparations (Levonorgestrel / Ethinyl Estradiol - 0.05/30 - 0.075/40 - 0.125/30)
- Triphasil
- Logynon (UK)
- Trivora
- Enpresse
- Components
- Levonorgestrel 0.05 to 0.125 mg (see preparation above)
- Ethinyl Estradiol 30 to 40 ug
- Effect
- Relative Progestational Activity: 0.5 (low)
- Estrogenic Activity: 28 (moderate)
- Androgenic Activity: 0.29 (moderate)
- Pill associated problems (Similar to Ortho-Novum 7/7/7)
- Indications to switch to Ortho Cyclen
- Acne Vulgaris (lower androgen)
- Increased Appetite (lower Progestin)
- Major Depression provoked (lower Progestin)
- Indications to switch to Demulen 1/35
- Breast Tenderness or engorgement (lower Estrogen)
- Headaches (lower Estrogen)
- Moodiness (less Estrogen or more Progestin)
- Weight gain (less Estrogen or more Progestin)
- Indications to switch to Modicon
- Break-through bleed days 1-9 (more Estrogen)
- Break-through bleed all of month (more Estrogen)
- Menses too light (more Estrogen, less Progestin)
- Indications to switch to Lo/Ovral
- Libido decreased (more androgen)
- Indications to switch to Ortho Novum 1/35
- Break-through bleed days 10-21 (more Progestin)
- Heavy Menses (more Progestin or less Estrogen)
- Dysmenorrhea or Menstrual Cramps (more Progestin)
- References
- Cerel-Suhl (1999) Am Fam Physician 60(7):2073 [PubMed]
- Speroff (1993) Obstet Gynecol 81:1034-47 [PubMed]
- Dickey (1998) Managing Contraceptive Pill Patients